Stereotactic Body Radiation Therapy for Prostate Cancer: An Institutional Experience Using MRI-guided Treatment Planning

With 222,500 new cases estimated for 2017, prostate cancer makes up approximately 10% of all new cancer diagnoses in the United States and is the third most common cancer after breast and lung cancer. In 2013, the American Society of Radiation Oncology (ASTRO) policy model recognized that stereotact...

Descripción completa

Detalles Bibliográficos
Autores principales: Waheed, Nabila L, Yoder, Alison K, Van Wyhe, Renae D, Carpenter, Steven L
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Cureus 2018
Materias:
Radiation Oncology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6037339/
https://www.ncbi.nlm.nih.gov/pubmed/30009104
http://dx.doi.org/10.7759/cureus.2590

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6037339/
https://www.ncbi.nlm.nih.gov/pubmed/30009104
http://dx.doi.org/10.7759/cureus.2590

Ejemplares similares